A carregar...

Attacking malignant cells that survive therapy: Exploiting immunogenic modulation

We have recently defined “immunogenic modulation,” a mechanism whereby malignant cells that survive anticancer therapy, due to sublethal delivery or development of treatment resistance, become nonetheless more sensitive to killing by cytotoxic T lymphocytes. This mechanism can be exploited to identi...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Hodge, James W, Kwilas, Anna, Ardiani, Andressa, Gameiro, Sofia R
Formato: Artigo
Idioma:Inglês
Publicado em: Landes Bioscience 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3902115/
https://ncbi.nlm.nih.gov/pubmed/24498561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4161/onci.26937
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!